Uptick Network
Halberd’s CEO on The Stock Day Podcast Breaking Down 20X Neutralizing Affinity SARS-COV-2 Antibody
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:12:07
- More information
Informações:
Synopsis
The Stock Day Podcast welcomed Halberd Corporation (OTC PINK:HALB)(“the Company”), a company that holds the exclusive rights to the patented extracorporeal treatment technology and the provisional patent applications associated with Covid-19. CEO and Chairman of the Company, William A Hartman, joined Stock Day host Everett Jolly.
